• 28TH FEBRUARY 2023

    Digital Communications and Policy Support Officer job opportunity

    PSNC is looking to recruit a new Digital Communications and Policy Support Officer. This role will support both our busy communications function (we send newsletters to our c.20,000 subscribers, as well as welcoming some 8,000 people daily to our website) and our LPC and wider Contractor Support. The role will report to the Pharmacy Communications

    Read more
    • 27TH FEBRUARY 2023

    Data Security and Protection Toolkit Workshop now on-demand

     Community pharmacy contractors can now access a recording of PSNC’s recent online workshop to help with completion of the Data Security and Protection Toolkit for 2022/2023. Feedback on the webinar “Very worthwhile watching.” “Perfect. To the point, no wasted time. Answer the questions clearly and concisely.” “I think it was long enough, slides were clear

    Read more
    • 27TH FEBRUARY 2023

    Service case study: Liverpool Community Pharmacy Sexual Health Service

    The Liverpool Community Pharmacy Sexual Health Service is commissioned by Liverpool University Hospitals NHS Foundation Trust, on behalf of Liverpool City Council, to provide sexual health services to the residents of Liverpool. The pharmacy service forms part of an integrated sexual health service offer, that incorporates community contraception services, genito-urinary medicine, and sexual health promotion.

    Read more
    • 27TH FEBRUARY 2023

    February SSP updates

    Pharmacy contractors should note a number of changes that have been made to different SSPs. SSP Extensions SSP029 for Sandrena® 0.5mg and 1mg gel sachets – restriction has been extended to 31 March 2023. It was previously set to expire on 28 February 2023. SSP030 for Sandrena® 0.5mg and 1mg gel sachets – substitution has been extended to

    Read more
    • 27TH FEBRUARY 2023

    MHRA Drug Safety Update February 2023

    A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 7 February 2023) has been published and includes articles on: COVID-19 vaccines and medicines: updates for February 2023 Letters and medicine recalls sent to healthcare professionals in January 2023 To see the latest MHRA Drug Safety Updates in full, visit

    Read more
    • 27TH FEBRUARY 2023

    Medicine Supply Notification: Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free)

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Latanoprost (Monopost®) 50 microgram/ml eye drops 0.2 ml unit dose (preservative free). MSN/2023/023 Tier 3 – high impact Date of issue 27th February 2023 Latanoprost (Monopost®) 50microgram/ml eye drops 0.2ml unit dose (preservative free) is out of stock until 17th March

    Read more
    • 27TH FEBRUARY 2023

    Drug Tariff Watch – March 2023

    The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 March 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item

    Read more
    • 27TH FEBRUARY 2023

    Class 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK)

    Class 4 Medicines Defect Information: Zestoretic 20mg/12.5mg tablets (Atnahs Pharma UK) Drug alert number: EL (23)A/05 Date issued: 27 February 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Zestoretic 20mg/12.5mg Tablets, PL 43252/0035 SNOMED Code: 17403011000001101 Batch number Expiry date Pack size First distributed

    Read more
    • 24TH FEBRUARY 2023

    Engaging with PSNC – please share your views

    From April 1st PSNC will be renaming to Community Pharmacy England and putting in place a new communications and engagement strategy. We want to engage better and more regularly with pharmacy owners, to hear more of your views and ideas, and to enable to you to input more directly into the organisation. As we develop

    Read more
    • 24TH FEBRUARY 2023

    Contractor Notice: Expiry of SSP048 Estradot® 50mcg patches

    The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Estradot® 50mcg patches are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP048 Estradot® 50mcg patches expires at 23.59pm on Friday 24 February 2023. After this date, any prescriptions for Estradot® 50mcg patches must be

    Read more